SCHEMBL14331318

SCHEMBL14331318

CC1(C)Cc2cc(C(N)=O)ccc2NC1c1cc(F)cc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 2/20 0.39
▸ KDM1A O60341 2/20 0.34
▸ OPRM1 P35372 2/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ PARP1 P09874 2/20 0.33
▸ MAPK14 Q16539 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ NNMT P40261 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ AKR1C3 P42330 1/20 0.31
▸ TTR P02766 1/20 0.31
▸ HTR1D P28221 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14331258 0.90 OPRM1 (0.36) SIRT2OPRM1OPRD1OPRK1MEN1
SCHEMBL2531412 0.89 MAPT (0.37) HTR7MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL14331349 0.88 HTR1D (0.35) SIRT2OPRM1OPRD1OPRK1ALDH1A1
SCHEMBL14331327 0.84 SIRT2 (0.37) SIRT2PARP1MAPK14HTR7MEN1
SCHEMBL2535709 0.83 AR (0.41) HTR7MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL2580211 0.82 SRD5A1 (0.37) HTR7MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL2530850 0.81 PARP1 (0.41) SIRT2OPRM1OPRD1OPRK1PARP1
SCHEMBL2530136 0.80 KDM4E (0.33) HTR7MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL2531308 0.80 KMO (0.43) HTR7MEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL12289256 0.80 LDHA (0.33) HTR7MEN1ALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 — — EP claimed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 — — US claimed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 — — EP claimed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 — — US claimed
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 — — EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 — — US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 — — EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 — — US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 SIRT2 284/4885KDM1A 413/4885OPRM1 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback